Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
OncoCyte Corporation (OCX) had Free Cash Flow per Share of $-0.24 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$2.14M |
|
$-6.67M |
|
$0.81M |
|
$1.32M |
|
$8.94M |
|
$-6.80M |
|
$0.13M |
|
$-6.67M |
|
$-6.67M |
|
$-6.67M |
|
$-6.67M |
|
$-6.67M |
|
$-6.67M |
|
$-6.80M |
|
$-6.31M |
|
25.69M |
|
25.69M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$36.26M |
|
$4.57M |
|
$24.10M |
|
$60.36M |
|
$9.68M |
|
$2.07M |
|
$40.46M |
|
$50.14M |
|
$10.22M |
|
$-4.38M |
|
$10.22M |
|
28.60M |
|
| Cash Flow Statement Financials | |
$-5.86M |
|
$-0.31M |
|
$28.56M |
|
$10.34M |
|
$32.73M |
|
$22.39M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.75 |
|
-- |
|
-- |
|
0.17 |
|
0.20 |
|
61.97% |
|
-318.01% |
|
-318.01% |
|
-- |
|
-312.02% |
|
-312.02% |
|
$-6.17M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
1.77 |
|
0.60 |
|
149.02 |
|
-65.29% |
|
152.24% |
|
-11.05% |
|
-54.27% |
|
$0.36 |
|
|
Free Cash Flow per Share |
$-0.24 |
$-0.23 |
|